Methylphenidate ER
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency is preparing to issue a national requirements contract for Methylphenidate ER Tablets in 18MG, 27MG, 36MG, and 54MG strengths, packaged in 100-count bottles. This procurement will be conducted as an unrestricted, fully competitive acquisition under FAR Part 12 as a commercial item, using a firm-fixed-price, requirements-type contract structure with a one-year base period and four one-year option periods. The resulting contract will serve as the national supply source for Methylphenidate ER Tablets, supplying the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons through the DLA and VA prime vendor programs. Annual usage estimates will be specified in the solicitation’s schedule, and all eligible sources may submit proposals. The contract is designed to ensure consistent, nationwide availability of this critical medication. The solicitation, numbered SPE2D226R0013, is currently in the pre-solicitation phase with a projected release date in September 2026, though the agency retains the right to issue it earlier or later. The contract will be posted on both the DLA Bid Board System and SAM.gov, and interested parties are encouraged to monitor these sites and set up automated notifications for updates. All correspondence should be directed to Jeremy Brown at jeremy.brown@dla.mil or (445) 737-5419, with Jason Wray available as a secondary point of contact. The acquisition is managed by DLA Troop Support, headquartered in Philadelphia, Pennsylvania, and is classified under NAICS code 325412 for pharmaceutical preparation manufacturing.
General Info
Agency
NAICS
Place of Performance
PASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Methylphenidate ER Tablets. Procurement details follow.
Methylphenidate ER 18MG, 27MG, 36MG, and 54MG Tablets in 100 count bottles.
This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of War, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.Gov at https://sam.gov. Interested parties should contact Jeremy Brown at (445) 737-5419, (jeremy.brown@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is September of 2026. DLA reserves the right to issue the solicitation before or after the projected solicitation date.